If not, have this conversation with your provider now
Retatrutide, as a triple agonist (GLP-1R + GIPR + GCGR) , is hypothesised to build on these benchmarks by adding the thermogenic and lipolytic effects attributed to glucagon receptor activation
Thus, scientists must note that unanticipated reactions may emerge as research progresses
By Alexey Markelov, MD, FACS If you have been following medical news lately, you have undoubtedly heard about GLP-1 agonistsmedications like Ozempic, Wegovy (semaglutide), and Mounjaro (tirzepatide)
As such, maintaining healthy blood pressure is crucial for longevity and quality of life
We observed knockdown of NRF2 protein and robust growth inhibition upon dox treatment, highlighting the dependency of these cell lines on NRF2 for growth (Fig